What is the risk of bleeding when adding a single antiplatelet agent and DAPT to oral anticoagulant therapy?
The addition of a single antiplatelet agent increased the risk of bleeding from a range of 2% to 3% to a range of 4% to 6%, whereas the addition of DAPT to oral anticoagulant therapy (triple therapy) increased the risk of bleeding from a range of 4% to 6% to a range of 10% to 14%.